ICU MEDICAL INC/DE (ICUI) Stock
ICUI has an Alpha Score of 29 out of 100 (poor), computed on Nov 6, 2026 from 3 of 4 sub-scores. 3 members of Congress disclosed 10 trades in ICUI since 2015: 5 purchases and 5 sales, most recently Gilbert Cisneros (partial sale, May 6, 2025). 5 of the hedge funds AlphaScala tracks reported ICUI in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Citadel's at $78.61M. Company insiders reported 0 open-market buys and 13 sales on SEC Form 4 in the 90 days to Nov 6, 2026. Its trailing P/E ratio is 143.1 and its net margin 1.4% (key statistics as of Nov 6, 2026).
What is ICUI's Alpha Score?
How it works →Alpha Score of 29 reflects poor overall profile with moderate momentum, poor value, poor quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Nov 6, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded ICU MEDICAL INC/DE (ICUI)?
Most recent: Gilbert Cisneros (partial sale, May 6, 2025); records start Feb 13, 2015.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Gil Cisneros D-CA · House | 2025-05-06 | partial sale | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2024-10-31 | partial sale | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2022-02-14 | purchase | $1k – $15k |
| Gil Cisneros D-CA · House | 2020-12-23 | partial sale | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2020-12-21 | partial sale | $1k – $15k |
| Gil Cisneros D-CA · House | 2020-09-25 | purchase | $1k – $15k |
| Gil Cisneros D-CA · House | 2020-09-24 | purchase | $15k – $50k |
| Gil Cisneros D-CA · House | 2020-09-23 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
See all ICUI political trades →Which hedge funds own ICUI?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Citadel Ken Griffin | 536K | $78.61M | +61% |
| Point72 Steve Cohen | 165K | $24.26M | +99% |
| Marshall Wace | 43K | $6.27M | +60% |
| D.E. Shaw David Shaw | 20K | $2.94M | NEW |
| Millennium Management Israel Englander | 7K | $970.5K | -90% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are ICU MEDICAL INC/DE insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Sep 3, 26 | Sanzone Virginia Ruth | VP, General Counsel | SELL | 2.2K | $369K |
| Sep 3, 26 | Sanzone Virginia Ruth | VP, General Counsel | SELL | 1.2K | $209K |
| Sep 3, 26 | Sanzone Virginia Ruth | VP, General Counsel | SELL | 724 | $123K |
| Sep 3, 26 | Sanzone Virginia Ruth | VP, General Counsel | SELL | 692 | $119K |
| Sep 1, 26 | Bonnell Brian Michael | Chief Financial Officer | SELL | 6.4K | $1.1M |
| Aug 31, 26 | Bonnell Brian Michael | Chief Financial Officer | SELL | 1.7K | $293K |
| Aug 31, 26 | Bonnell Brian Michael | Chief Financial Officer | SELL | 1.9K | $329K |
| Aug 31, 26 | Bonnell Brian Michael | Chief Financial Officer | SELL | 4.6K | $792K |
| Aug 31, 26 | Bonnell Brian Michael | Chief Financial Officer | SELL | 1.1K | $194K |
| Aug 13, 26 | Woolson Daniel | VP, GM-Infusion Capital | SELL | 5.4K | $982K |
SEC Form 4 filings as of Nov 6, 2026
See cluster-buy signals across all tickers →What are ICUI's key statistics?
Key statistics as of Nov 6, 2026
How does ICUI's valuation compare with the Healthcare sector?
| Metric | ICUI | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 143.1 | 28.8 | 111 |
| Net margin | 1.39% | 3.66% | 168 |
| Return on equity | 1.41% | 3.80% | 191 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 8, 2026). P/E excludes loss-making companies.
ICUI price chart
Powered by TradingViewWhat does ICU MEDICAL INC/DE do?
ICU Medical Inc. is a medical technology company that develops, manufactures, and sells innovative medical devices for infusion therapy, vascular access, and vital care applications worldwide. Its product portfolio spans three key business segments: Consumables, featuring infusion sets, vascular access products, and specialty chemicals; Infusion Systems, including ambulatory, syringe, and large volume IV pumps with safety software, dedicated and non-dedicated IV sets, needle-free connectors, and informatics services; and Vital Care, offering hemodynamic monitoring, temperature management, airway management, and pain kits. Notable products include needlefree connectors under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock and ChemoClave closed system transfer devices for hazardous drugs; Tego needle-free connectors; Deltec GRIPPER non-coring needles; and various IV therapy solutions like sodium chloride, dextrose, and irrigation products. ICU Medical Inc. serves acute care hospitals, ambulatory clinics, alternate site facilities, and home care settings through direct sales, independent distributors, and partnerships, with a global presence across the U.S., Europe, Asia-Pacific, Middle East, Africa, and other regions. Founded in 1984 and headquartered in San Clemente, California, it plays a critical role in enhancing patient safety, preventing bloodstream infections, and protecting healthcare workers from hazardous exposures in the medical devices sector.